TLDR
- Mizuho unveiled its July favorites, featuring Robinhood, Erasca, EyePoint, Encompass Health, and Corteva
- Robinhood shares climbed 8.4% midweek; Mizuho maintains an Outperform stance with a $115 target
- Micron leads Mizuho’s semiconductor selections with a $1,375 target following exceptional Q3 performance
- Oracle receives a $320 valuation from Mizuho, citing artificial intelligence as a crucial expansion catalyst
- Micron reports earnings September 29, 2026, coinciding with anticipated HBM pricing negotiations
Mizuho Securities unveiled its monthly selection of preferred investments for July on Thursday, introducing five fresh names spanning multiple industries. The roster features Robinhood Markets, Erasca, EyePoint, Encompass Health, and Corteva.
Robinhood stock experienced an 8.4% surge on Wednesday and continued its momentum with an additional 3% gain during Thursday’s premarket session, touching $111.99. Dan Dolev, an analyst at Mizuho, maintains an Outperform recommendation alongside a $115 price objective.
Dolev emphasized that Robinhood has successfully “captured the zeitgeist of a generation” while persistently launching innovative offerings. He highlighted global expansion efforts, prediction markets, and futures trading capabilities as pivotal catalysts for future performance.
Mizuho also noted that Robinhood’s TradePMR acquisition strategically mitigates worries about customers migrating toward conventional financial advisory services.
Micron Maintains Leadership Position Following Earnings Correction
Micron remains Mizuho’s premier selection within the semiconductor space. The company’s shares skyrocketed more than 15% on June 24 following third-quarter earnings disclosure of $25.11 per share, significantly exceeding the $20.98 consensus estimate. Revenue registered at $41.46 billion, substantially surpassing Wall Street’s $35.91 billion projection.
This revenue achievement marks a remarkable 345.8% year-over-year increase. Subsequently, Micron experienced a 6.7% retreat on Friday with trading volume nearly doubling typical levels.
Mizuho elevated its valuation from $1,150 to $1,375. Additional analysts joined with enhanced targets, including Susquehanna at $2,000 and Needham at $1,650. Among 39 analysts tracking the company, 31 maintain Buy recommendations.
Vijay Rakesh, an analyst, projects sustained memory demand momentum through 2027, predominantly fueled by artificial intelligence applications. He characterized Micron as a “key winner” within the industry.
Apple’s CEO Tim Cook recently characterized the memory scarcity as a “once in a century flood.” Elon Musk amplified his remarks, describing the supply-demand imbalance as “insane.”
Digitimes research suggests HBM pricing could escalate to 2.5 times 2026 levels during upcoming annual supply contract discussions. These negotiations typically occur each fall, and Micron’s September 29 earnings announcement aligns perfectly with this critical timeframe.
Oracle Strategically Positioned for Artificial Intelligence Expansion
Oracle completes Mizuho’s highlighted selections within the enterprise software category. Siti Panigrahi, an analyst, assigns an Outperform rating with a $320 target price. Oracle shares declined 2.8% on Wednesday to $142.50, before recovering 1.3% during Thursday’s premarket trading.
Mizuho emphasized that Oracle’s comprehensive AI infrastructure spanning database technology, cloud infrastructure, and application layers positions the company advantageously for sustained artificial intelligence adoption trends.
The investment firm projects AI-driven revenue will generate annual operating income expansion of 34% extending through fiscal 2030. Mizuho acknowledged Oracle will probably require additional capital infusions to support its AI infrastructure investments.
Micron’s Q4 2026 outlook anticipates $30.00 to $32.00 earnings per share, surpassing Wall Street consensus. All 25 analyst adjustments during the past 90 days have reflected upward revisions.
